Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis

Summary

Allogeneic human umbilical cord tissue-derived stem cells will be injected intravenously once per day for 5 days is a safe and useful procedure in inducing remission of RA in patients resistant to standard DMARD therapy.

Timeline

Start

2013-10

Primary completion

2019-12

Completion

2020-06

Drugs

Indications